Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00481130 · ClinicalTrials.gov registry record
Alport Syndrome Treatments and Outcomes Registry
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 655
- Enrollment target
NCT00481130 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 655 participants.
The verdict
NCT00481130 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 655 participants
- Enrollment target
Study Summary
ASTOR's primary purpose is to enroll families and patients with a history of Alport syndrome in a central registry. The information we gather will be used as a basis for studies designed to test potential treatments for Alport syndrome. ASTOR also aims to provide patients, families and physicians with the most up-to-date information about Alport syndrome.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 655 participants |
| Start Date | 2007-09 |
| Est. Completion | 2025-11-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00481130
The ClinicalTrials.gov registry entry for NCT00481130 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 655 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00481130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00481130 about?
NCT00481130 is a clinical study titled "Alport Syndrome Treatments and Outcomes Registry". ASTOR's primary purpose is to enroll families and patients with a history of Alport syndrome in a central registry. The information we gather will be used as a basis for studies designed to test potential treatments for Alport syndrome. ASTOR also aims to provide patients, families and physicians wi...
What is the current status of trial NCT00481130?
This trial is currently completed. The enrollment target is 655 participants. The study started on 2007-09. Estimated completion is 2025-11-17.
Who is sponsoring clinical trial NCT00481130?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.